HCC - HEPATOCELLULAR CARCINOMA
Clinical trials for HCC - HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HCC - HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for HCC - HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple-Threat attack on tough liver cancer shows promise
Disease control OngoingThis study is looking at a three-part treatment for people with intermediate to advanced liver cancer who cannot have surgery. It combines a procedure to cut off the tumor's blood supply and deliver chemo, followed by precise radiation and a drug that helps the immune system figh…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug trial tests immune system 'Decoy' to fight advanced tumors
Disease control OngoingThis early-stage study is testing a new immunotherapy drug called DECOY20, both alone and combined with another cancer drug (tislelizumab), in people with advanced solid tumors that have stopped responding to standard treatments. The main goals are to find safe doses, check for s…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Indaptus Therapeutics, Inc • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
AI crystal ball for liver cancer? study tests prediction tool
Knowledge-focused OngoingThis study is testing whether a computer program (machine learning model) can accurately predict which liver cancer patients are at high risk of their cancer spreading to other organs like the lungs or bones after initial treatment. It involves 800 patients who have already had t…
Matched conditions: HCC - HEPATOCELLULAR CARCINOMA
Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated Apr 04, 2026 06:20 UTC